Amy-P53

N/A

Report date: 2025/06/11 11:07:38
NME

Base Information

Drug NameAmy-P53
Drug Alias Namedual alpha-synuclein/beta amyloid antagonist (Amypore)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionBeta amyloid A4 protein inhibitorsNeuroprotectantsSynuclein alpha inhibitors
TargetsSynuclein alphaBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmyPore
China Registration ClassN/A

Develop Information

Active CompaniesAmyPore
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A